The offer price of $26.25 per share represents a significant premium, making this a highly favorable outcome for TBRG shareholders. Monitor for shareholder vote results and regulatory approvals, as the deal is expected to close in Q3 2026. The stock price should converge to the offer price, minus any risk of deal failure.
Price Chart
Executive Summary
TruBridge, Inc. (TBRG) is being acquired by Inventurus Knowledge Solutions, Inc. (IKS Health) in an all-cash transaction valued at approximately $557 million, or $26.25 per share. The deal is expected to close in Q3 2026, subject to shareholder and regulatory approvals. This is a significant, transformative event for the company.
Key Financial Metrics
Key Facts
- TruBridge, Inc. (TBRG) is being acquired by Inventurus Knowledge Solutions, Inc. (IKS Health) in an all-cash transaction.
- The transaction price is $26.25 per share.
- The enterprise value of the deal is approximately $557 million.
- The deal is expected to close in the third calendar quarter of 2026.
- Closing is subject to shareholder approval and regulatory clearances, including the Hart-Scott-Rodino (HSR) review.
- TBRG will be delisted from NASDAQ upon closing.
- The strategic rationale is to combine IKS's strengths in ambulatory revenue cycle management (RCM) with TBRG's expertise in acute care RCM and EHR for rural and community hospitals.
Financial Impact
The transaction has an enterprise value of approximately $557 million, with shareholders receiving $26.25 per share in cash.
Risk Factors
- The transaction is subject to customary closing conditions, including shareholder approval, which is not guaranteed.
- Regulatory approvals, including the Hart-Scott-Rodino (HSR) notification and waiting period, could be delayed or result in conditions that are not anticipated.
- There is a risk that the merger agreement could be terminated due to unforeseen events or changes in circumstances.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-173636 |
| Document: 0001193125-26-173636-index-headers.html | 0001193125-26-173636 |
| Document: 0001193125-26-173636-index.html | 0001193125-26-173636 |
| Document: 0001193125-26-173636.txt | 0001193125-26-173636 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 15w ago | 8-K | $26.24 | awaiting T+20 | — | — |
May 21, 2026 22w ago | PREM14A | $25.94 $26.12 | ▲ +0.69% | ▲ +2.11% | — |
Apr 23, 2026 26w ago | DEFA14A | $25.77 $25.90 | ▲ +0.50% | ▼ −3.52% | — |
Apr 23, 2026 26w ago | DEFA14A | $25.77 $25.90 | ▲ +0.50% | ▼ −3.52% | — |
Apr 23, 2026 26w ago | DEFA14A | $25.76 $25.94 | ▲ +0.70% | ▼ −3.94% | — |
Apr 23, 2026 26w ago | 8-K | $25.76 $25.94 | ▲ +0.70% | ▼ −3.94% | — |
Mar 31, 2026 29w ago | 8-K | $15.65 $25.73 | ▲ +64.41% | ▲ +54.69% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers